Return On Assets of CRISPR Therapeutics AG from 30 Jun 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CRISPR Therapeutics AG quarterly and annual Return On Assets in % history and change rate from 30 Jun 2017 to 30 Sep 2025.
  • CRISPR Therapeutics AG Return On Assets for the quarter ending 30 Sep 2025 was -22%, a 117% decline year-over-year.
  • CRISPR Therapeutics AG annual Return On Assets for 2024 was -16%, a 125% decline from 2023.
  • CRISPR Therapeutics AG annual Return On Assets for 2023 was -7%, a 74% increase from 2022.
  • CRISPR Therapeutics AG annual Return On Assets for 2022 was -27%, a 286% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CRISPR Therapeutics AG Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -22% -12% -117% 01 Jul 2025 30 Sep 2025
Q2 2025 -22% -10% -84% 01 Apr 2025 30 Jun 2025
Q1 2025 -17% -7% -77% 01 Jan 2025 31 Mar 2025
Q4 2024 -16% -9% -125% 01 Oct 2024 31 Dec 2024
Q3 2024 -10% +6% +36% 01 Jul 2024 30 Sep 2024
Q2 2024 -12% +7% +37% 01 Apr 2024 30 Jun 2024
Q1 2024 -10% +13% +57% 01 Jan 2024 31 Mar 2024
Q4 2023 -7% +20% +74% 01 Oct 2023 31 Dec 2023
Q3 2023 -16% +11% +40% 01 Jul 2023 30 Sep 2023
Q2 2023 -18% +5% +23% 01 Apr 2023 30 Jun 2023
Q1 2023 -23% -34% -300% 01 Jan 2023 31 Mar 2023
Q4 2022 -27% -41% -286% 01 Oct 2022 31 Dec 2022
Q3 2022 -27% -44% -254% 01 Jul 2022 30 Sep 2022
Q2 2022 -24% -46% -209% 01 Apr 2022 30 Jun 2022
Q1 2022 11% +36% 01 Jan 2022 31 Mar 2022
Q4 2021 14% +40% 01 Oct 2021 31 Dec 2021
Q3 2021 17% +36% 01 Jul 2021 30 Sep 2021
Q2 2021 22% +20% +972% 01 Apr 2021 30 Jun 2021
Q1 2021 -25% -30% -549% 01 Jan 2021 31 Mar 2021
Q4 2020 -26% -36% -370% 01 Oct 2020 31 Dec 2020
Q3 2020 -18% -16% -796% 01 Jul 2020 30 Sep 2020
Q2 2020 2% +42% 01 Apr 2020 30 Jun 2020
Q1 2020 6% +45% 01 Jan 2020 31 Mar 2020
Q4 2019 10% +48% 01 Oct 2019 31 Dec 2019
Q3 2019 -2% +29% +93% 01 Jul 2019 30 Sep 2019
Q2 2019 -40% -12% -41% 01 Apr 2019 30 Jun 2019
Q1 2019 -40% -15% -63% 01 Jan 2019 31 Mar 2019
Q4 2018 -38% -15% -64% 01 Oct 2018 31 Dec 2018
Q3 2018 -31% -15% -89% 01 Jul 2018 30 Sep 2018
Q2 2018 -28% -15% -115% 01 Apr 2018 30 Jun 2018
Q1 2018 -24% 01 Jan 2018 31 Mar 2018
Q4 2017 -23% 01 Oct 2017 31 Dec 2017
Q3 2017 -16% 01 Jul 2017 30 Sep 2017
Q2 2017 -13% 01 Apr 2017 30 Jun 2017

CRISPR Therapeutics AG Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -16% -9% -125% 01 Jan 2024 31 Dec 2024
2023 -7% +20% +74% 01 Jan 2023 31 Dec 2023
2022 -27% -41% -286% 01 Jan 2022 31 Dec 2022
2021 14% +40% 01 Jan 2021 31 Dec 2021
2020 -26% -36% -370% 01 Jan 2020 31 Dec 2020
2019 10% +48% 01 Jan 2019 31 Dec 2019
2018 -38% -15% -64% 01 Jan 2018 31 Dec 2018
2017 -23% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.